Literature DB >> 18524806

Non-traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation but not thrombophilia.

C Séguin1, J Kassis, L Busque, A Bestawros, J Theodoropoulos, M-L Alonso, E J Harvey.   

Abstract

OBJECTIVE: The pathophysiology of non-traumatic osteonecrosis (ON) or avascular necrosis (AVN) of the femoral head remains poorly understood. Some studies have suggested the contribution of underlying thrombophilia as a mechanism; however, no specific thrombophilic factor has been consistently found in association with the disease. We are presenting data suggesting a role for endothelial cell activation rather than thrombophilia in ON.
METHODS: A prospective consecutive cohort of 49 patients with a diagnosis of ON. The disease was considered idiopathic in five and secondary in 44 patients. The investigation included a coagulation and thrombophilia profile, endothelial cell activation and non-specific inflammatory markers as well as a biochemical profile. Statistical analysis using Fisher's exact test was obtained to assess correlation between endothelial cell markers and variables of inflammation.
RESULTS: Patients with non-traumatic ON were not found to have a specific underlying thrombophilic factor compared with the general population. Out of 49 patients,19 had elevation of at least one endothelial cell markers. We found that activation of endothelial cell markers was independently correlated to ON but not correlated to the presence of inflammation (P = 1.0000).
CONCLUSION: These results suggest that non-traumatic ON is not associated with a specific thrombophilic abnormality in those affected. This study demonstrates a potential association between regional endothelial dysfunction and ON. More studies are needed at a molecular level to further investigate the specific role of endothelium in the physiopathology of ON. A better understanding of the underlying mechanism could lead to potential preventive and therapeutic strategies of this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524806     DOI: 10.1093/rheumatology/ken206

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

1.  Screening for thrombophilia does not identify patients at risk of portal or splenic vein thrombosis following laparoscopic splenectomy.

Authors:  Namdar Manouchehri; Pepa Kaneva; Chantal Séguin; Giovanni P Artho; Liane S Feldman
Journal:  Surg Endosc       Date:  2015-08-26       Impact factor: 4.584

Review 2.  Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis.

Authors:  Christian Powell; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

3.  Microarchitectural and mechanical characterization of the sickle bone.

Authors:  Mykel Green; Idowu Akinsami; Angela Lin; Shereka Banton; Samit Ghosh; Binbin Chen; Manu Platt; Ifeyinwa Osunkwo; Solomon Ofori-Acquah; Robert Guldberg; Gilda Barabino
Journal:  J Mech Behav Biomed Mater       Date:  2015-04-24

Review 4.  Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.

Authors:  Annamaria Aprile; Silvia Sighinolfi; Laura Raggi; Giuliana Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-11

5.  Extracellular Vesicles from BMSCs Prevent Glucocorticoid-Induced BMECs Injury by Regulating Autophagy via the PI3K/Akt/mTOR Pathway.

Authors:  Jinhui Ma; Mengran Shen; Debo Yue; Weiguo Wang; Fuqiang Gao; Bailiang Wang
Journal:  Cells       Date:  2022-07-03       Impact factor: 7.666

6.  New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model.

Authors:  Mohammad Amin Kerachian; Denis Cournoyer; Edward J Harvey; Terry Y Chow; Louis R Bégin; Ayoub Nahal; Chantal Séguin
Journal:  Arthritis Res Ther       Date:  2010-06-25       Impact factor: 5.156

7.  Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors.

Authors:  Elisabetta Cenni; Caterina Fotia; Enis Rustemi; Kimitachi Yuasa; Giuseppe Caltavuturo; Armando Giunti; Nicola Baldini
Journal:  Acta Orthop       Date:  2011-02-01       Impact factor: 3.717

8.  Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland.

Authors:  Jacek Gagala; Monika Buraczynska; Tomasz Mazurkiewicz; Andrzej Ksiazek
Journal:  BMC Musculoskelet Disord       Date:  2013-09-11       Impact factor: 2.362

Review 9.  Osteonecrosis of the Femoral Head in Patients with Hypercoagulability-From Pathophysiology to Therapeutic Implications.

Authors:  Elena Rezus; Bogdan Ionel Tamba; Minerva Codruta Badescu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

10.  Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head.

Authors:  Wayne Mah; Swapnil K Sonkusare; Tracy Wang; Bouziane Azeddine; Mihaela Pupavac; Jian Carrot-Zhang; Kwangseok Hong; Jacek Majewski; Edward J Harvey; Laura Russell; Colin Chalk; David S Rosenblatt; Mark T Nelson; Chantal Séguin
Journal:  J Med Genet       Date:  2016-06-21       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.